TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

ACADIA Pharmaceuticals Inc (ACAD)

Healthcare Biotechnology
25.90 $
-2.6% vs. previous close
Closing price · As of: 31. Jul 2026

ACADIA Pharmaceuticals Inc (ACAD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,564 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet ACAD
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
325 222 561 385 540 783 783 700 588 749 1,188 1,564
325 219 548 373 526 760 718 618 508 616 938 1,062
62 102 164 69 135 190 326 147 115 189 320 178
322 215 529 341 474 697 632 521 417 439 756 820
1.0 1.6 7.1 18 28 38 50 65 63 102 105 148
0.0 0.0 4.2 5.2 4.1 6.3 9.7 7.9 6.6 36 22 35
0.6 2.2 3.1 2.7 3.3 3.2 9.2 66 62
0.0 0.0 0.0 0.0 0.0
0.0 0.0 7.0 5.5 4.1 2.6 1.1 65 120 109
16 22 43 49 61 84 156 159 187 317 455 337
16 22 43 49 60 75 106 96 126 254 395 277
3.4 5.1 8.3 9.3 9.4 10.0 12
2.0 1.7 3.9 8.8 3.2 7.2 8.5 6.9 13 18 16 11
0.0 0.0 0.0 0.0
309 200 518 335 479 699 627 541 400 432 733 1,227
-498 -663 -934 -1,224 -1,469 -1,704 -1,986 -2,154 -2,370 -2,431 -2,204 -1,813
97 101 116 123 127 147 157 160 162 164 166 171

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?